John Goodman

1 week ago | independent.org | Brady Leonard |Ethan Yang |John Goodman |Phillip W. Magness

Hours after sweeping, near-global tariffs went into effect Wednesday morning, the Trump administration paused nearly all new tariffs, aside from the astronomical 125% tariff placed on Chinese goods. Tariffs that were not temporarily suspended include a near-universal 10% tariff on most imports and a 25% tariff on foreign made vehicles.

1 week ago | independent.org | John Goodman |Phillip W. Magness |K. Lloyd Billingsley |Ross Marchand

Some time ago, my think tank commissioned Dr. Lori Taylor, at that time an economics professor at Southern Methodist University, to do a study of Dallas public schools. The study measured the productivity of the schools by comparing the test scores of students in the current year with the scores of those same students in the previous year.

1 week ago | independent.org | Phillip W. Magness |K. Lloyd Billingsley |Ross Marchand |John Goodman

For Immediate ReleaseApril 15, 2025Oakland, Calif.—The concept of “creative destruction” was introduced by economist Joseph Schumpeter to describe the natural process by which competitive markets dismantle established practices, thus making way for innovation. That process needs to occur in American higher education—but is blocked by regulations and subsidies from government and short-sighted donors.

Oct 29, 2024 | healthaffairs.org | John Goodman

In a frequently cited June 2022 article in Health Affairs, Sherry A. Glied, Dahlia K. Remler, and Mikaela Springsteen argue that health savings accounts (HSAs) are no longer functioning as originally advertised and suggest that we abolish them as tax-favored accounts. Fortunately, there are better options. Instead of abolishing these accounts, we could turn them into vehicles for patients to get more cost-effective, higher-quality care—including the management of chronic illness. What Is An HSA?

Aug 26, 2024 | independent.org | John Goodman

For at least half a century, we have been struggling with three health policy problems that never seem to go away: cost, quality and access to care. This is the case even though public policy has been actively trying to solve all three—with increasing aggressiveness through time. Over the past 50 years, medical science has improved. Today, we know more and we can do more. We have better drugs, better diagnostic tools and better therapeutics. And we have better outcomes.